Peihong Zhang

发表

Associations between gender , disease features and symptom burden in the MPN population : An analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016 .

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.

K. Döhner, M. Griesshammer, T. Barbui, 2017, Leukemia research.

Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs

K. Döhner, M. Griesshammer, T. Barbui, 2015 .

Calreticulin mutations in Chinese with primary myelofibrosis

Bing Li, Bing Li, R. Gale, 2014, Haematologica.

Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R

Bing Li, R. Gale, Yue Zhang, 2016, Oncotarget.

Distinct characteristics and new prognostic scoring system for Chinese patients with Waldenström macroglobulinemia

Jianxiang Wang, L. Qiu, G. An, 2014, Chinese medical journal.

Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response

Bing Li, Yue Zhang, T. Qin, 2018, Blood Cancer Journal.

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis

Bing Li, R. Gale, Yue Zhang, 2017, Journal of Hematology & Oncology.

CALR mutation screening in pediatric primary myelofibrosis

Jingliao Zhang, Yang Wan, Xiaojuan Chen, 2014, Pediatric blood & cancer.

Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis.

Bing Li, R. Gale, Yue Zhang, 2014, Leukemia research.

Unique features of primary myelofibrosis in Chinese.

R. Gale, Yue Zhang, T. Qin, 2012, Blood.

The different prognostic impact of type‐1 or type‐1 like and type‐2 or type‐2 like CALR mutations in patients with primary myelofibrosis

Bing Li, Yue Zhang, T. Qin, 2016, American journal of hematology.

Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms

Bing Li, T. Qin, Zhijian Xiao, 2022, Leukemia.

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms

Bing Li, T. Qin, Yingying Zhao, 2022, Haematologica.

Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study

Bing Li, T. Qin, Zhijian Xiao, 2022, Hematological oncology.

Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors

Shaoping Ling, T. Zhu, Jianfeng Zhou, 2016, Oncotarget.

The Significance of Bone Marrow Involvement in Aggressive Lymphomas: A Retrospective Comparison of Clinical Outcomes between Peripheral T Cell Lymphoma and Diffuse Large B Cell Lymphoma in China

L. Qiu, G. An, Yao-zhong Zhao, 2010, Acta Haematologica.

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

K. Döhner, M. Griesshammer, T. Barbui, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

M. Griesshammer, T. Barbui, A. Dueck, 2013 .

Palpitations And Arrhythmia In 3649 High-Risk Patients With Essential Thrombocythemia : Results From The Prospective Long-Term Observational Exels Study

T. Barbui, A. Dueck, R. Mesa, 2016 .

CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia

Bing Li, R. Gale, Q. Jiang, 2014, Journal of Hematology & Oncology.

Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization classification system

S. Kojima, Wenyu Yang, Xiaofan Zhu, 2012, International Journal of Hematology.

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016, Haematologica.

High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival

K. Ru, Jianxiang Wang, T. Cheng, 2015, Oncotarget.

Morphologic Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report

Y. Mi, B. Eyden, Y. Ru, 2014, Ultrastructural pathology.

Transcriptome Analysis of Monozygotic Twin Brothers with Childhood Primary Myelofibrosis

Wenyu Yang, Nan Ding, Lan Ren, 2017, Genom. Proteom. Bioinform..

Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response

Bing Li, Yue Zhang, T. Qin, 2018, Blood Cancer Journal.

Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression

Bing Li, T. Qin, Zhijian Xiao, 2023, Blood cancer journal.

RBC distribution width predicts thrombosis risk in polycythemia vera

Bing Li, R. Gale, T. Qin, 2021, Leukemia.

Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre

Bing Li, R. Gale, Jiaxi Zhou, 2020, Blood Cancer Journal.

Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center

Bing Li, R. Gale, T. Qin, 2022, Haematologica.

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

M. Griesshammer, T. Barbui, A. Dueck, 2016 .

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera

Bing Li, R. Gale, T. Qin, 2021, Blood Cancer Journal.

[CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].

Bing Li, Q. Jiang, Yue Zhang, 2014, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

CALR mutation screening in pediatric primary myelofibrosis

Jingliao Zhang, Xiaojuan Chen, W. An, 2014, Pediatric Blood & Cancer.

Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy

Bing Li, T. Qin, Zhijian Xiao, 2023, Leukemia research reports.

Distinguishing myelodysplastic syndromes with moderate‐to‐severe bone marrow fibrosis from triple‐negative primary myelofibrosis based on clinical and genetic covariates

T. Qin, Zhijian Xiao, L. Pan, 2022, Hematological oncology.

Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis

Bing Li, L. Pan, W. Cai, 2024, Leukemia.

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.

K. Döhner, M. Griesshammer, T. Barbui, 2017, Leukemia research.

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016, Haematologica.